Consolidated Biosciences ApS: Financial statements 2023
CVR: 40180230
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Consolidated Biosciences ApS (CVR 40180230) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -54,375 and a net result of DKK -1,719,344 compared with DKK -1,002,210 the year before. Equity in the 2023 report amounted to DKK 1,257,651. The solvency ratio was 1.3%.
- Gross Profit
- DKK -54,375
- Profit/Loss
- DKK -1,719,344
- Equity
- DKK 1,257,651
- Total Assets
- DKK 98,438,144
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -54K | -1.7M | 1.3M | - |
| 2022 | - | -46K | -1M | 3M | - |
| 2021 | - | -34K | -1.1M | -1M | - |
| 2020 | - | -43K | -585K | 65K | - |
| 2019 | - | -25K | -430K | 50K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Consolidated Biosciences ApS has published its annual report for 2022. Gross profit came to DKK -45,625, and the net result was DKK -1,002,210.
About Consolidated Biosciences ApS
Consolidated Biosciences ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2019. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Lone Schøtt Kunøe. The company is owned by CENTRAL EUROPEAN FOOD PRODUCTION COMPANY ApS, CONSOLIDATED HOLDINGS A/S and L1 HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,501 and a net result of DKK -1,814,488 compared with DKK -1,740,301 the year before. Equity in the 2025 report amounted to DKK 202,862.